Literature DB >> 20152345

Peritoneal drainage does not stabilize extremely low birth weight infants with perforated bowel: data from the NET Trial.

Clare M Rees1, Simon Eaton, A Kate Khoo, Edward M Kiely, Agostino Pierro.   

Abstract

INTRODUCTION: Proponents of peritoneal drainage (PD) hypothesize that it allows stabilization before laparotomy. We examined this hypothesis by comparing clinical status before and after either PD or primary laparotomy (LAP).
METHODS: In an ethically approved, international, prospective randomized controlled trial (2002-2006), extremely low birth weight (<1000 g) infants with pneumoperitoneum received primary PD (n = 35) or LAP (n = 34). Physiologic data were collected prospectively and organ failure scores calculated and compared between preprocedure and day 1 after procedure. Data, expressed as mean +/- SD or median (range), were analyzed using appropriate statistical tests.
RESULTS: There was no postprocedure improvement in either PD or LAP group comparing heart rate (PD, P = 1.0; LAP, P = .6), blood pressure (PD, P = .6; LAP, P = .8), inotrope requirement (PD, P = .2; LAP, P = .3), or Arterial partial pressure of oxygen/fraction of inspired oxygen ratio (PD, P = .1; LAP, P = .5). Infants managed with PD had a worsening cardiovascular status (P = .05). There were no differences in total organ failure score in either group (PD, P = .5; LAP, P = 1). Only 4 infants survived with PD alone with no difference between preprocedure and postprocedure organ failure score (P = .4).
CONCLUSIONS: Peritoneal drainage does not immediately improve clinical status in extremely low birth weight infants with bowel perforation. The use of PD as a stabilizing or temporizing measure is not supported by these results. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152345     DOI: 10.1016/j.jpedsurg.2009.10.066

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Primary laparotomy is effective and safe in the treatment of necrotizing enterocolitis.

Authors:  Stefan Gfroerer; Henning Fiegel; Rolf L Schloesser; Udo Rolle
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

2.  Outcomes and costs of surgical treatments of necrotizing enterocolitis.

Authors:  Anne Stey; Elizabeth S Barnert; Chi-Hong Tseng; Emmett Keeler; Jack Needleman; Mei Leng; Lorraine I Kelley-Quon; Stephen B Shew
Journal:  Pediatrics       Date:  2015-04-13       Impact factor: 7.124

Review 3.  Necrotizing enterocolitis.

Authors:  Josef Neu; W Allan Walker
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

4.  Meconium obstruction in absence of cystic fibrosis in low birth weight infants: an emerging challenge from increasing survival.

Authors:  Valentina Filomena Paradiso; Vito Briganti; Lucia Oriolo; Riccardo Coletta; Alessandro Calisti
Journal:  Ital J Pediatr       Date:  2011-11-14       Impact factor: 2.638

Review 5.  The timing of ostomy closure in infants with necrotizing enterocolitis: a systematic review.

Authors:  Marie-Chantal Struijs; Cornelius E J Sloots; Wim C J Hop; Dick Tibboel; Rene M H Wijnen
Journal:  Pediatr Surg Int       Date:  2012-04-21       Impact factor: 1.827

6.  Impact of an In-House Pediatric Surgery Unit and Human Milk Centered Enteral Nutrition on Necrotizing Enterocolitis.

Authors:  Sonja Zamrik; Federica Giachero; Michael Heldmann; Kai O Hensel; Stefan Wirth; Andreas C Jenke
Journal:  Biomed Res Int       Date:  2018-11-13       Impact factor: 3.411

7.  Primary peritoneal drainage in neonates with necrotizing enterocolitis associated with congenital heart disease: a single experience in a Brazilian tertiary center.

Authors:  W C Canesin; F A P Volpe; W A Gonçalves-Ferri; P H Manso; D C Aragon; L Sbragia
Journal:  Braz J Med Biol Res       Date:  2021-05-31       Impact factor: 2.590

8.  Usefulness of peritoneal drainage in extremely low birth weight infants with intestinal perforation: a single-center experience.

Authors:  Ju Yeon Lee; Jung-Man Namgoong; Seong Chul Kim; Dae Yeon Kim
Journal:  Ann Surg Treat Res       Date:  2020-02-28       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.